Clinical Trial Update: AMISH : Aprovel for Management of Isolated Systolic Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluated Aprovel (irbesartan) for the management of isolated systolic hypertension. The study sponsored by Sanofi has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Isolated Systolic Hypertension

Drugs mentioned

• Aprovel (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED